Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
248.50    0.00 (0.00%)
Bid:
241.00
Ask:
245.00
Spread: 4.00 (1.66%)
Market Cap: £144.97m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Board Appointment

23 Dec 2008 10:42

RNS Number : 6781K
Gleeson(M J)Group PLC
23 December 2008
 



Tuesday, 23 December 2008

M J GLEESON GROUP PLC

Christopher Mills appointed a non-executive Director

Gleeson (GLE.L), the urban regeneration and strategic land specialist, is pleased to announce the appointment as a non-executive Director, with effect from 1 January 2009, of Christopher Mills. Christopher Mills is a member and Chief Investment Officer of North Atlantic Value LLP. North Atlantic Value LLP, which has been a substantial shareholder since March 2005, currently has an equity stake of 18.2% in M J Gleeson Group plc

Christopher Harwood Bernard Mills, 56, is also Chief Investment Officer of J O Hambro Capital Management Limited, which he joined in 1993. Mr Mills is additionally Chief Executive and Investment Manager of North Atlantic Smaller Companies Investment Trust PLC, a UK listed investment trust, and a Director and investment manager of Oryx International Growth Fund Limited. From 1975 to 1993, Christopher worked for Samuel Montagu Limited, Montagu Investment Management Limited and its successor company, Invesco MIM.

In addition to North Atlantic Smaller Companies Investment Trust PLC, Christopher Mills has been a director of the following publicly quoted companies within the previous five yearsAlbany Capital Plc, Castle Support Services PLC, Catalyst Media Group plc, Inspired Gaming Group plc, Izodia PLC , Mid-States PLC (until 17 December 2008), Prime Focus London PLC and Sirvis IT plc 

Dermot GleesonChairman, stated: "Christopher Mills' vast experience and expertise in the field of investment management will very helpfully supplement and enhance the collective skills of the Gleeson Board". 

Save as disclosed above, there are no details to be disclosed under paragraph 9.6.13 R of the Listing Rules. 

Enquiries:

M J Gleeson Group plc 01252-360 300

Dermot Gleeson (non-executive Chairman)

Bankside Consultants Limited

Charles Ponsonby  020-7367 8851

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABGBDDCXDGGIX
Date   Source Headline
30th Nov 20237:00 amRNSTotal Voting Rights
27th Nov 20234:29 pmRNSDirector/PDMR Shareholding
16th Nov 20231:33 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Update
8th Nov 20233:29 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
24th Oct 20234:17 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:56 pmRNSExercise of Options & Director/ PDMR Dealing
17th Oct 20237:00 amRNSNotice of AGM
6th Oct 20232:37 pmRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSTotal Voting Rights
27th Sep 20234:17 pmRNSExercise of Options & PDMR Dealing
26th Sep 20234:38 pmRNSDirector/PDMR Shareholding
15th Sep 20233:54 pmRNSDirector/PDMR Shareholding
15th Sep 202310:35 amRNSDirector/PDMR Shareholding
14th Sep 20234:41 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
7th Sep 202312:20 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSTotal Voting Rights
8th Aug 20234:55 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSTotal Voting Rights
7th Jul 20233:48 pmRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSTrading Update and Capital Markets Day
30th Jun 20237:00 amRNSSale of portfolio of homes to Carlyle
30th Jun 20237:00 amRNSTotal Voting Rights
8th Jun 20232:23 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
15th May 20233:30 pmRNSHolding(s) in Company
10th May 20231:56 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTotal Voting Rights
14th Apr 202310:01 amRNSDirector/PDMR Shareholding
6th Apr 202311:13 amRNSDirector/PDMR Shareholding
5th Apr 20234:37 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSRe Directorate
21st Mar 20237:00 amRNSNotice of Capital Markets Day and Trading Update
13th Mar 20233:58 pmRNSSigning of the Self-Remediation Terms
8th Mar 20235:13 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSTotal Voting Rights
27th Feb 202312:05 pmRNSPerformance Share Plan award to Directors & PDMRs
16th Feb 20237:00 amRNSResults for the half-year ended 31 December 2022
8th Feb 20235:18 pmRNSCommittee appointments
8th Feb 20231:45 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
13th Jan 20237:00 amRNSTrading Update & Notice of Results
6th Jan 20234:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSRe Directorate
30th Dec 20227:00 amRNSTotal Voting Rights
15th Dec 202211:06 amRNSDirectorate External Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.